Skip to main content
OpenTrials
Completed

NCT Number: NCT07459023

Changes in Scalp Condition After Using a Moisturizer: a Prospective Clinical Trial Using Artificial Intelligence

The goal of this clinical trial is to evaluate whether a scalp moisturizer containing celastrol and Cichorium intybus root extract can improve scalp condition in adults aged 19 years or older who require scalp moisturization due to dryness, scaling, erythema, or dandruff. The main questions it aims to answer are:

Does once-daily application of the study moisturizer improve scalp condition from baseline to week 4, as assessed by SPI-AI (Scalp Photographic Index-Artificial Intelligence)?

Does the moisturizer improve scalp biophysical parameters (erythema index, stratum corneum hydration, and transepidermal water loss) and patient-reported symptom severity over the 4-week treatment period?

Participants will:

Apply the study moisturizer once daily at bedtime to dry scalp for 4 weeks and rinse it off the following morning using their usual shampoo.

Attend study visits at baseline (week 0), week 2, and week 4 for scalp imaging, biophysical measurements, symptom questionnaires, adherence assessment, and safety monitoring.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Kyeonggi, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥19 years
  • Presence of scalp erythema, dryness, scaling, or dandruff requiring scalp moisturization

Exclusion criteria

  • Active infectious scalp dermatoses
  • Use of topical or systemic therapies affecting scalp status within 4 weeks prior to enrollment or during the study period
  • Inability to comply with the study protocol

Treatment and study plan

Ducray Kertyol P.S.O. Concentrate Cream, Ducray Laboratory, France

Other

participants applied the moisturizer once daily to the entire scalp at bedtime

Primary outcomes

  1. SPI-AI

    Time frame: 4week

    Scalp Photographic Index with artificial intelligence

Secondary outcomes

  1. SPI-AI

    Time frame: 2week

    Scalp Photographic Index with artificial intelligence

  2. Biophysical parameter

    Time frame: 2week

    erythema index (arbitrary unit)

  3. Biophysical parameter

    Time frame: 4week

    erythema index (arbitrary unit)

  4. Biophysical parameter

    Time frame: 2 week

    corneometer (arbitrary unit)

  5. Biophysical parameter

    Time frame: 4 week

    corneometer (arbitrary unit)

  6. Biophysical parameter

    Time frame: 2 week

    transepidermal water loss (g/m2/h)

  7. Biophysical parameter

    Time frame: 4 week

    transepidermal water loss (g/m2/h)

  8. Patient-reported outcome

    Time frame: 2 week

    visual analog scale (0-10) : higher is worse

  9. Patient-reported outcome

    Time frame: 4 week

    visual analog scale (0-10) : higher is worse

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

Changes in Scalp Condition After Using a Moisturizer Containing Celastrol and Cichorium Intybus Root Extract: a Prospective Clinical Trial Using Artificial Intelligence

Acronym: scalp

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 9, 2026
Registry last updated
Mar 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.